Cargando…

Increased Frequency of Activated Switched Memory B Cells and Its Association With the Presence of Pulmonary Fibrosis in Diffuse Cutaneous Systemic Sclerosis Patients

Disease-associated, high-affinity pathological autoantibody production is a well-described consequence of immune dysregulation affecting B cells in systemic sclerosis (SSc), including the distribution of B-cell subsets. We have previously shown that the increased relative frequency of CD19+CD27+IgD−...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simon, Diána, Balogh, Péter, Erdő-Bonyár, Szabina, Böröcz, Katalin, Minier, Tünde, Czirják, László, Berki, Tímea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278062/ https://www.ncbi.nlm.nih.gov/pubmed/34276673 http://dx.doi.org/10.3389/fimmu.2021.686483

Ejemplares similares

Analysis of PI3K Pathway Associated Molecules Reveals Dysregulated Innate and Adaptive Functions of B Cells in Early Diffuse Cutaneous Systemic Sclerosis
por: Simon, Diána, et al.
Publicado: (2021)

Ligation of TLR Homologue CD180 of B Cells Activates the PI3K/Akt/mTOR Pathway in Systemic Sclerosis and Induces a Pathological Shift in the Expression of BAFF Receptors
por: Erdő-Bonyár, Szabina, et al.
Publicado: (2022)

Toll-Like Receptor Mediated Activation of Natural Autoantibody Producing B Cell Subpopulations in an Autoimmune Disease Model
por: Erdő-Bonyár, Szabina, et al.
Publicado: (2019)

Complexity of the Immune Response Elicited by Different COVID-19 Vaccines, in the Light of Natural Autoantibodies and Immunomodulatory Therapies
por: Böröcz, Katalin, et al.
Publicado: (2023)

Following Natural Autoantibodies: Further Immunoserological Evidence Regarding Their Silent Plasticity and Engagement in Immune Activation
por: Szinger, David, et al.
Publicado: (2023)

Relationship between natural and infection‐induced antibodies in systemic autoimmune diseases (SAD): SLE, SSc and RA
por: Böröcz, K., et al.
Publicado: (2020)

Anti-Neuronal Autoantibodies (Cell Surface and Onconeural) and Their Association With Natural Autoantibodies in Synthetic Cannabinoid-Induced Psychosis
por: Hau, Lídia, et al.
Publicado: (2022)

Toll-Like Receptor Homolog CD180 Expression Is Diminished on Natural Autoantibody-Producing B Cells of Patients with Autoimmune CNS Disorders
por: Hayden, Zsófia, et al.
Publicado: (2021)

Different Kinetics of Serum ADAMTS13, GDF-15, and Neutrophil Gelatinase-Associated Lipocalin in the Early Phase of Aneurysmal Subarachnoid Hemorrhage
por: Csecsei, Peter, et al.
Publicado: (2023)

Physiological Changes in the Levels of Anti-Cytokine Autoantibodies in Early Pregnancy Are Missing in Pregnant Women with Hashimoto's Thyroiditis
por: Erdő-Bonyár, Szabina, et al.
Publicado: (2023)

Single‐center study of autoimmune encephalitis‐related autoantibody testing in Hungary
por: Hayden, Zsófia, et al.
Publicado: (2019)

Optimization of Lyophilized Hyperacute Serum (HAS) as a Regenerative Therapeutic in Osteoarthritis
por: Olmos Calvo, Isabel, et al.
Publicado: (2021)

Serum Periostin May Help to Identify Patients with Poor Collaterals in the Hyperacute Phase of Ischemic Stroke
por: Spantler, Dora, et al.
Publicado: (2022)

Dynamic Features of Herd Immunity: Similarities in Age-Specific Anti-Measles Seroprevalence Data between Two Countries of Different Epidemiological History
por: Böröcz, Katalin, et al.
Publicado: (2022)

Measles Vaccination and Outbreaks in Croatia from 2001 to 2019; A Comparative Study to Other European Countries
por: Drenjančević, Ines, et al.
Publicado: (2022)

Minimal Clinically Important Differences (MCID) for the Functional Assessment of Chronic Illness Therapy Fatigue Scale in Patients with Systemic Sclerosis
por: Kiss, Franciska, et al.
Publicado: (2022)

Characteristics of ScleroID highlighting musculoskeletal and internal organ implications in patients afflicted with systemic sclerosis
por: Nagy, Gabriella, et al.
Publicado: (2023)

Splenectomy modulates the immune response but does not prevent joint inflammation in a mouse model of RA
por: Khanfar, Esam, et al.
Publicado: (2022)

Hemizygous nonsense variant in the moesin gene (MSN) leads to a new autoimmune phenotype of Immunodeficiency 50
por: Kovács, András L., et al.
Publicado: (2022)

Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: a EUSTAR analysis
por: Dobrota, Rucsandra, et al.
Publicado: (2016)

Presence of TRPA1 Modifies CD4+/CD8+ T Lymphocyte Ratio and Activation
por: Szabó, Katalin, et al.
Publicado: (2022)

Natural and Pathological Autoantibodies Show Age-Related Changes in a Spontaneous Autoimmune Mouse (NZB) Model
por: Gál, Szonja, et al.
Publicado: (2023)

Osteopontin levels are associated with late-time lower regional brain volumes in multiple sclerosis
por: Orsi, Gergely, et al.
Publicado: (2021)

Health Assessment Questionnaire-Disability Index (HAQ-DI) use in modelling disease progression in diffuse cutaneous systemic sclerosis: an analysis from the EUSTAR database
por: Allanore, Yannick, et al.
Publicado: (2020)

Ameliorated Autoimmune Arthritis and Impaired B Cell Receptor-Mediated Ca(2+) Influx in Nkx2-3 Knock-out Mice
por: Khanfar, Esam, et al.
Publicado: (2020)

Patients with Systemic Sclerosis with and without Overlap Syndrome Show Similar Microvascular Abnormalities
por: Nagy, Gabriella, et al.
Publicado: (2021)

Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial
por: Khanna, Dinesh, et al.
Publicado: (2020)

Sine scleroderma, limited cutaneous, and diffused cutaneous systemic sclerosis survival and predictors of mortality
por: De Almeida Chaves, Sébastien, et al.
Publicado: (2021)

Lymphocyte subset abnormalities in early diffuse cutaneous systemic sclerosis
por: Fox, David A., et al.
Publicado: (2021)

Patient perception of disease burden in diffuse cutaneous systemic sclerosis
por: Khanna, Dinesh, et al.
Publicado: (2019)

AZD-1222: Diffuse cutaneous systemic sclerosis: case report
Publicado: (2022)

Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS)
por: Herrick, Ariane L, et al.
Publicado: (2017)

Verification of P-Glycoprotein Function at the Dermal Barrier in Diffusion Cells and Dynamic “Skin-On-A-Chip” Microfluidic Device
por: Bajza, Ágnes, et al.
Publicado: (2020)

Molecular Analysis of Cystic Fibrosis Patients in Hungary – An Update to the Mutational Spectrum
por: Ivády, Gergely, et al.
Publicado: (2015)

Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study
por: Peytrignet, Sébastien, et al.
Publicado: (2018)

Structural and Functional Analysis of Excised Skins and Human Reconstructed Epidermis with Confocal Raman Spectroscopy and in Microfluidic Diffusion Chambers
por: Kocsis, Dorottya, et al.
Publicado: (2022)

Correction to: Lymphocyte subset abnormalities in early diffuse cutaneous systemic sclerosis
por: Fox, David A., et al.
Publicado: (2021)

Initial evidence of presence of papillary muscle diffuse fibrosis in patients with cardiomyopathy
por: Kato, Shingo, et al.
Publicado: (2015)

Systemic sclerosis cutaneous expression: Management of skin fibrosis and digital ulcers
por: Starnoni, Marta, et al.
Publicado: (2021)

Application of a fast and cost-effective ‘three-in-one’ MMR ELISA as a tool for surveying anti-MMR humoral immunity: the Hungarian experience
por: Böröcz, K., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t2t5p86p4l8pt67p0e1uqg2ejt